Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

The Series C funding round was spearheaded by Alpha Wave Ventures and saw contributions from several current investors.

Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most ...

Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

The "Hypodermic Syringes and Needles Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The Hypodermic ...

SAN DIEGO, April 10, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART ® ...

Mizuho initiated coverage of Embecta (EMBC) with a Neutral rating and $15 price target The firm says its rating balances the company’s ...

Authors Key Points Media Contact For general and media inquiries and to book our experts, please contact: [email protected] Introduction The United States may finally be turning the tide on the overdose ...